Literature DB >> 20849551

Transplantation outcomes in primary hyperoxaluria.

E J Bergstralh1, C G Monico, J C Lieske, R M Herges, C B Langman, B Hoppe, D S Milliner.   

Abstract

Optimal transplantation strategies are uncertain in primary hyperoxaluria (PH) due to potential for recurrent oxalosis. Outcomes of different transplantation approaches were compared using life-table methods to determine kidney graft survival among 203 patients in the International Primary Hyperoxaluria Registry. From 1976-2009, 84 kidney alone (K) and combined kidney and liver (K + L) transplants were performed in 58 patients. Among 58 first kidney transplants (32 K, 26 K + L), 1-, 3- and 5-year kidney graft survival was 82%, 68% and 49%. Renal graft loss occurred in 26 first transplants due to oxalosis in ten, chronic allograft nephropathy in six, rejection in five and other causes in five. Delay in PH diagnosis until after transplant favored early graft loss (p = 0.07). K + L had better kidney graft outcomes than K with death-censored graft survival 95% versus 56% at 3 years (p = 0.011). Among 29 year 2000-09 first transplants (24 K + L), 84% were functioning at 3 years compared to 55% of earlier transplants (p = 0.05). At 6.8 years after transplantation, 46 of 58 patients are living (43 with functioning grafts). Outcomes of transplantation in PH have improved over time, with recent K + L transplantation highly successful. Recurrent oxalosis accounted for a minority of kidney graft losses. ©2010 The Authors Journal compilation©2010 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849551      PMCID: PMC2965313          DOI: 10.1111/j.1600-6143.2010.03271.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  37 in total

Review 1.  Transplantation strategies in type 1 primary hyperoxaluria: the issue of pyridoxine responsiveness.

Authors:  M Marangella
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

2.  A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004.

Authors:  Neville V Jamieson
Journal:  Am J Nephrol       Date:  2005-06-15       Impact factor: 3.754

3.  Primary hyperoxaluria type 2: enzymology.

Authors:  C F Giafi; G Rumsby
Journal:  J Nephrol       Date:  1998 Mar-Apr       Impact factor: 3.902

Review 4.  Selection of transplantation procedures and perioperative management in primary hyperoxaluria type 1.

Authors:  K Latta; N V Jamieson; J I Scheinman; K Schärer; A Bensman; P Cochat; C Legendre; H Ruder; L de Pauw; C Toussaint
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

5.  Are there guidelines for a strategy according to glomerular filtration rate, plasma oxalate determination and the risk of oxalate accumulation?

Authors:  T M Barratt; W G van't Hoff
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

6.  Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele.

Authors:  Carla G Monico; Sandro Rossetti; Julie B Olson; Dawn S Milliner
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

Review 7.  The primary hyperoxalurias: an algorithm for diagnosis.

Authors:  Dawn S Milliner
Journal:  Am J Nephrol       Date:  2005-04-22       Impact factor: 3.754

8.  Transplantation for primary hyperoxaluria in the United States.

Authors:  P Saborio; J I Scheinman
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

9.  Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival.

Authors:  Hélady Sanders Pinheiro; Niels Olsen Saraiva Câmara; Kikumi Suzete Osaki; Luiz Antonio Ribeiro De Moura; Alvaro Pacheco-Silva
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

10.  The European Primary Hyperoxaluria Type 1 Transplant Registry report on the results of combined liver/kidney transplantation for primary hyperoxaluria 1984-1994. European PH1 Transplantation Study Group.

Authors:  N V Jamieson
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

View more
  46 in total

1.  Crystalline bone marrow in systemic oxalosis.

Authors:  Joseph C Chiovaro; Anuj Gaggar
Journal:  J Gen Intern Med       Date:  2014-06       Impact factor: 5.128

2.  End Points for Clinical Trials in Primary Hyperoxaluria.

Authors:  Dawn S Milliner; Tracy L McGregor; Aliza Thompson; Bastian Dehmel; John Knight; Ralf Rosskamp; Melanie Blank; Sixun Yang; Sonia Fargue; Gill Rumsby; Jaap Groothoff; Meaghan Allain; Melissa West; Kim Hollander; W Todd Lowther; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-12       Impact factor: 8.237

Review 3.  Primary hyperoxalurias: diagnosis and treatment.

Authors:  Efrat Ben-Shalom; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2014-12-18       Impact factor: 3.714

Review 4.  Liver involvement in kidney disease and vice versa.

Authors:  Karen Van Hoeve; Djalila Mekahli; Eva Morava; Elena Levtchenko; Peter Witters
Journal:  Pediatr Nephrol       Date:  2017-06-23       Impact factor: 3.714

5.  A non-resolving skin lesion in hemodialysis patient: Answers.

Authors:  Shimrit Tzvi-Behr; Efrat Ben-Shalom; Rachel Becker-Cohen; Graciela Lijozetzky; Jenny Weinbrand-Goichberg; Yaacov Frishberg; Choni Rinat
Journal:  Pediatr Nephrol       Date:  2018-08-28       Impact factor: 3.714

6.  Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning.

Authors:  Marine Le Dudal; Léa Huguet; Joëlle Perez; Sophie Vandermeersch; Elise Bouderlique; Ellie Tang; Carole Martori; Nicole Chemaly; Rima Nabbout; Jean-Philippe Haymann; Vincent Frochot; Laurent Baud; Georges Deschênes; Michel Daudon; Emmanuel Letavernier
Journal:  J Clin Invest       Date:  2019-04-04       Impact factor: 14.808

7.  siRNA Therapeutics for Primary Hyperoxaluria: A Beginning.

Authors:  Dawn S Milliner
Journal:  Mol Ther       Date:  2016-04       Impact factor: 11.454

Review 8.  Genetic testing for kidney disease of unknown etiology.

Authors:  Thomas Hays; Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2020-04-24       Impact factor: 10.612

9.  Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.

Authors:  Xiaojing Tang; Nikolay V Voskoboev; Stacie L Wannarka; Julie B Olson; Dawn S Milliner; John C Lieske
Journal:  Am J Nephrol       Date:  2014-04-26       Impact factor: 3.754

Review 10.  Primary disease recurrence—effects on paediatric renal transplantation outcomes.

Authors:  Justine Bacchetta; Pierre Cochat
Journal:  Nat Rev Nephrol       Date:  2015-04-28       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.